Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Dalhousie University

$24,000.00

Regulation of cell metabolism by omega-3 polyunsaturated fatty acids

EF 2013-14

Résumé
DPA Industries Inc. is a Canadian corporation with over 15 years experience producing and exportingCanadian-made omega-3 polyunsaturated fatty acid products. The flagship product is DPA GOLD Omega-3; ahighly refined and purified omega-3, available in oil and capsule form. The business and its products are called'DPA' after docosapentaenoic acid - a third important component found in omega-3.Metabolic dysfunction leads to deregulation of cellular homeostasis thereby altering the metabolism of the cell.Amongst the various dietary products that have been implicated in normal cellular function are the omega-3and omega-6 polyunsaturated fatty acids (n3-PUFAs/n6-PUFAs). Despite decades of research, detailedunder-standing of how PUFAs improve cell function is not fully understood. Given consumer interest indifferent sources of n3-PUFA, we will compare the effects of docosapentanoic acid (DPA; DPA Industries Inc)and docosahexaenoic acid (DHA; Enzo Life Sciences) from marine sources, and on cell metabolism andmitochondria function.Overall, the outcome of our study will determine whether there are differences between the various sources ofn3-PUFA, at the molecular level. We will analyze the effects of DPA vs DHA treatment on mitochondriafunction and cell migration, providing DPA Industries with scientific data to support their claims of thebeneficial effects of n3-PUFA DPA on cell biology. This will allow a framework from which to market theirproduct amongst marine sources of n3-PUFA.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
461136-2013
Name nom
Marignani, Paola
Department département
Biochemistry and Molecular Biology
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
24000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
1
Nb partie
1
Application title
Regulation of cell metabolism by omega-3 polyunsaturated fatty acids
Keyword
NSERC
Application summary
DPA Industries Inc. is a Canadian corporation with over 15 years experience producing and exportingCanadian-made omega-3 polyunsaturated fatty acid products. The flagship product is DPA GOLD Omega-3; ahighly refined and purified omega-3, available in oil and capsule form. The business and its products are called'DPA' after docosapentaenoic acid - a third important component found in omega-3.Metabolic dysfunction leads to deregulation of cellular homeostasis thereby altering the metabolism of the cell.Amongst the various dietary products that have been implicated in normal cellular function are the omega-3and omega-6 polyunsaturated fatty acids (n3-PUFAs/n6-PUFAs). Despite decades of research, detailedunder-standing of how PUFAs improve cell function is not fully understood. Given consumer interest indifferent sources of n3-PUFA, we will compare the effects of docosapentanoic acid (DPA; DPA Industries Inc)and docosahexaenoic acid (DHA; Enzo Life Sciences) from marine sources, and on cell metabolism andmitochondria function.Overall, the outcome of our study will determine whether there are differences between the various sources ofn3-PUFA, at the molecular level. We will analyze the effects of DPA vs DHA treatment on mitochondriafunction and cell migration, providing DPA Industries with scientific data to support their claims of thebeneficial effects of n3-PUFA DPA on cell biology. This will allow a framework from which to market theirproduct amongst marine sources of n3-PUFA.